Speaking at the STAT Summit, Kyle and Nicole Muldoon shared an inside look at how their family went from heartbreak to ...

As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...

The race to advance gene editing tech continues, spurred on by starry-eyed Silicon Valley investors, entrepreneurs and even ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we ...

Trying to figure out what to do with Intellia Therapeutics stock? You’re definitely not alone. After all, this is a company that’s been on quite the rollercoaster lately. Over just the past week, ...

Significant advancements in gene silencing and gene editing offer new hope for treating rare disorders. Techniques like RNA ...

When startup Pairwise launched Conscious Greens, a line of CRISPR-edited mustard greens, consumers got to experience ...

Faulty versions of the LMNA gene can cause a wide range of health problems, including heart muscle disease (dilated ...

CRISPR Therapeutics recently presented new preclinical data at the ESGCT 2025 Annual Congress showing its investigational CTX460, using the SyNTase gene editing platform, achieved greater than 90% ...

The agreement gives Chiesi exclusive rights for the development and commercialisation of ABO-101 to treat PH1.

From curing inherited disorders to modifying crops and even animal species, gene editing has moved from science fiction to daily reality—raising questions science can’t ignore.

MIT researchers have dramatically lowered the error rate of prime editing, a technique with promise for treating numerous ...